Invention Grant
- Patent Title: Nuclear receptor modulators
-
Application No.: US15176309Application Date: 2016-06-08
-
Publication No.: US10106501B2Publication Date: 2018-10-23
- Inventor: Maria A. Argiriadi , Eric C. Breinlinger , Kevin P. Cusack , Adrian D. Hobson , Dominique Potin , Martine Barth , Jerome Amaudrut , Olivia Poupardin , Laurent Mounier , Michael E. Kort
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Priority: WOPCT/IB2015/001693 20150609
- Main IPC: C07D209/08
- IPC: C07D209/08 ; C07D401/10 ; C07D403/10 ; C07D401/14 ; C07D405/12 ; C07D401/06 ; C07D491/107 ; C07D405/14 ; C07D235/06 ; C07D471/04 ; C07D487/04 ; C07D231/56 ; C07D235/16 ; C07D405/10 ; C07D491/10 ; C07D209/14 ; C07D209/18
Abstract:
The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
Public/Granted literature
- US20160362370A1 NUCLEAR RECEPTOR MODULATORS Public/Granted day:2016-12-15
Information query
